SCHAUMBURG, Ill., March 19, 2014 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB:WCUI), a healthcare and medical solutions provider, today announced that Dr. Jay Joshi, MD, WCUI's Chief Medical Officer, was recently featured in one of CNN's key debates on medical marijuana for chronic pain. His thoughts, insight, and expertise as a national key opinion leader within the field of pain management were helpful in clarifying the confusion and debate surrounding medical marijuana.
The article, titled "Minister's daughter: Cannabis 'a gift from God'" presents a chronic pain patient who was able to find relief of her chronic pain with medical marijuana when other FDA medications did not work. Recently, there has been a great deal of discussion about medical marijuana, its benefits, risks, and prescribing issues. Dr. Joshi provided balanced and compelling commentary about the utility of medical marijuana, the logistical issues, and the current hysteria surrounding marijuana in general.
He stated that the debate should not be about whether cannabis-based medications help with pain, rather, they should be about how we can safely help patients without jumping into conclusions that all treatments are good or bad. No medications are risk-free and all can have potential side effects. It is important to have a top-tier physician who understands all forms of appropriate and safe treatment options and, more importantly, can diagnose individuals correctly. If all physicians met that criteria, we would have more success, greater patient function, less side effects, lower healthcare costs, and lower prescription abuse (opiates, marijuana, etc).
The full article is available to read at:
http://www.cnn.com/2014/03/07/health/cannabis-pain/index.html
Dr. Jay Joshi is a nationally recognized board certified Anesthesiologist and fellowship trained Interventional Spine and Pain Management physician who has distinguished himself via his solid reputation, education, experience, and leadership via national activities, including Advisory Boards, Educational and CME Programs, Publications, Speaking Events, Consulting, and Media Appearances. He is considered a National Key Opinion Leader in pain management and he is presented to a variety of audiences, both large and small, over 500 times.
Read Dr. Joshi's full biography at:
http://wellnesscenterusa.com/images/PDF/Dr. Jay Joshi BIO.pdf
About Wellness Center USA, Inc.
Wellness Center USA, Inc. (www.wellnesscenterusa.com) an alternative healthcare, medical device solutions and online nutraceutical sales company, was created to address important healthcare and wellness needs; through break-through solutions, centered on the "well-being of the body and mind". Wellness Center USA, Inc.'s three business units are:
National Pain Centers, Inc. (NPC) (www.nationalpaincenters.com) is an Illinois based company that focuses on diagnosis, treatment, research, advocacy, education, and setting standards and protocols within interventional and multi-modal pain management. Pain management is the most common and most unknown medical condition in the United States, and costs Americans over $635 billion a year. NPC manages Interventional Spine and Pain procedures that include Epidural Steroid Injections, Selective Nerve Root Blocks, Facet Joint Medial Branch Injections, Radiofrequency Ablation, Sympathetic Blocks, Spinal Cord Stimulators, Percutaneous Discectomy, and Discograms. NPC is also involved in research and progressive treatment options such as Ketamine Infusions and Stem Cell Therapy. These services and procedures are overseen by its well respected physician, Dr. Jay Joshi. Through proper interventional and non-interventional protocols, ethical practices, and innovative treatment options, patients from all over the U.S. have seen relief from their pain.
Psoria-Shield Inc. (www.psoria-shield.com) is a Tampa FL based company specializing in design, manufacturing, and distribution of medical devices to domestic and international markets. PSI employs full-time engineering, production, sales staff, and manufactures within an ISO 13485 certified quality system. PSI's flagship product, Psoria-Light®, is FDA-cleared and CE marked and delivers targeted UV phototherapy for the treatment of certain skin disorders. Psoria-Shield Inc., was acquired by Wellness Center USA Inc. ("WCUI") in August 2012, and is now a wholly-owned subsidiary.
CNS-Wellness (www.cns-wellness.com) is a Tampa FL based cognitive science clinic business, specializing in the treatment of behavioral health disorders in at least three focus areas: a) stress related disorders including anxiety and panic attacks, depression, and obsessive-compulsive spectrum disorders, b) developmental and learning disorders such as autistic spectrum issues and Asperger's syndrome, AD/HD, learning differences and birth trauma-related issues, and c) purely brain-based issues including epilepsy and seizure disorders, traumatic brain injuries, and related acquired brain syndromes. CNS-Wellness LLC, was acquired by Wellness Center USA Inc. ("WCUI") in August 2012, and is now a wholly-owned subsidiary.
AminoFactory (www.aminofactory.com), a division of Wellness Center USA, Inc., is an online supplement store that markets and sells a wide range of high-quality nutritional vitamins and supplements. By utilizing AminoFactory's online catalog, bodybuilders, athletes, and health conscious consumers can choose and purchase the highest quality nutritional products from a wide array of offerings in just a few clicks.
Safe Harbor Statement:
Certain statements contained in this news release that are not statements of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include statements regarding the proposed exchange transaction, the anticipated closing date of the transaction and anticipated future results following a closing of the transaction. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transaction, and which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transaction, difficulties in integrating operations following the transaction, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.